Discover
AMPH
Amphastar Pharmaceuticals, Inc.
20.42
1 x 20.01
1 x 20.82
bid
ask
+
0.11
0.54%
1466 @ 04:00 PM
20.42 +0.00 (0.00%)
| Ytd | -23.75% | |
| 1y | -25.37% |
20.00
day range
20.57
16.65
52 week range
31.26
| Open | 20.02 | Prev Close | 20.31 | Low | 20.00 | High | 20.57 | Mkt Cap | 900.38M |
| Vol | 0.00 | Avg Vol | 592.67K | EPS | 2.93 | P/E | 6.97 | Forward P/E | 5.49 |
| Beta | 0.89 | Short Ratio | 11.61 | Inst. Own | 75.56% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 19.68 | 200-d Avg | 22.85 | 1yr Est | 31.29 |
| Income Statement | |||
| Total Revenue | 183.90M | ||
| Revenues (USD) | 183.90M | ||
| Cost of Revenue | 90.43M | ||
| Gross Profit | 93.47M | ||
| Operating Expenses | 53.74M | ||
| Research and Development Expense | 22.16M | ||
| Selling, General and Administrative Expense | 31.58M | ||
| Operating Income | 39.73M | ||
| Interest Expense | 6.66M | ||
| Income Tax Expense | 8.20M | ||
| Net Income | 30.35M | ||
| Net Income Common Stock | 30.35M | ||
| Net Income Common Stock (USD) | 30.35M | ||
| Consolidated Income | 30.35M | ||
| Earnings per Basic Share | 0.69 | ||
| Earnings per Basic Share (USD) | 0.69 | ||
| Earnings per Diluted Share | 0.67 | ||
| Earning Before Interest & Taxes (EBIT) | 45.20M | ||
| Earning Before Interest & Taxes (USD) | 45.20M | ||
| Weighted Average Shares | 43.64M | ||
| Weighted Average Shares Diluted | 44.23M | ||
| Balance Sheet | |||
| Cash and Equivalents | 223.85M | ||
| Cash and Equivalents (USD) | 223.85M | ||
| Investments | 68.71M | ||
| Investments Current | 68.71M | ||
| Trade and Non-Trade Receivables | 144.86M | ||
| Current Assets | 630.95M | ||
| Property, Plant & Equipment Net | 389.13M | ||
| Total Assets | 1.74B | ||
| Debt Current | 11.29M | ||
| Total Debt | 688.32M | ||
| Current Liabilities | 263.21M | ||
| Debt Non-Current | 677.03M | ||
| Total Liabilities | 975.61M | ||
| Accumulated Retained Earnings (Deficit) | 703.65M | ||
| Accumulated Other Comprehensive Income | -5.90M | ||
| Shareholders Equity | 768.16M | ||
| Shareholders Equity (USD) | 768.16M | ||
| Assets Non-Current | 1.11B | ||
| Total Debt (USD) | 688.32M | ||
| Goodwill and Intangible Assets | 647.83M | ||
| Inventory | 179.91M | ||
| Liabilities Non-Current | 712.40M | ||
| Trade and Non-Trade Payables | 251.37M | ||
| Tax Assets | 45.09M | ||
| Tax Liabilities | 6.47M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 16.46M | ||
| Net Cash Flow from Financing | -43.53M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 52.68M | ||
| Capital Expenditure | -8.59M | ||
| Issuance (Purchase) of Equity Shares | -45.21M | ||
| Issuance (Repayment) of Debt Securities | -525.00K | ||
| Net Cash Flow from Investing | 44.87M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 55.32M | ||
| Net Cash Flow from Operations | 51.32M | ||
| Effect of Exchange Rate Changes on Cash | 16.00K | ||
| Share Based Compensation | 7.09M | ||